person
Diego T.
- Country
- France
- Department
- Oncologie médicale
Research Overview
assignment
43
Clinical Trials ·
- Phase I Study of OT-A201 in Patients with Relapsed/Refractory Hematological Malignancies or Advanced/Metastatic Solid Tumors
- Evaluation of [Main Substance] in Combination with Other Agents in Patients with Advanced Solid Tumors
- Phase I Study of PhOx430, a Glucosaminyltransferase V Inhibitor, in Adults with Advanced or Metastatic Solid Tumors Lacking Effective Treatment Options
location_city
1
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
239
Sites with multiple studies
Has run more than one trial at 239 of 508 partner sites.
Specializations
Urological Oncology
This investigator specializes in various forms of urological cancers, with particular focus on bladder cancer, urothelial carcinoma, and metastatic renal cell carcinoma.
- Muscle-invasive bladder cancer treatment
- Advanced urothelial cancer therapies
- Renal cell carcinoma management
Prostate Cancer Research
The investigator has significant expertise in treating metastatic castration-resistant prostate cancer and developing novel therapeutic approaches for prostate malignancies.
- Advanced prostate cancer treatments
- Hormone therapy combinations
- Targeted therapeutic approaches
Advanced Solid Tumors
The investigator conducts research on various advanced solid tumors, including gastric cancer, colorectal cancer, and rare tumor types.
- Gastrointestinal malignancies
- Novel therapeutic combinations
- First-in-human studies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.